Jun Wang

68PUBLICATIONS
85CO-AUTHORS
Major global burdens of diseaseGene and molecular therapyPharmacogenomicsNutritional epidemiologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|May 01, 2026
Rational Design of Capsid Protein VP1 Degraders to Overcome Pleconaril Resistance in Inhibiting Enterovirus D68.

|Apr 27, 2026
Initiation of Long-Acting Antiretroviral Combinations Achieve Sustained Virologic Remission in Early-Life SIV Infection.

|Feb 19, 2026
Characterization of the Cross-Resistance of SARS-CoV‑2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and Nirmatrelvir.

Haozhou Tan, Xiang Chi, Xufang Deng

|Feb 10, 2026
Rational design and in vivo validation of capsid inhibitors for enterovirus D68.

Kan Li, Michael J Rudy, Thomas Klose

|Jan 30, 2026
Structure-Based Design of Covalent SARS-CoV‑2 Main Protease Inhibitors Targeting the Nirmatrelvir-Resistant E166 Mutants.

Zhengjun Cai, Navita Kohaal, Kyriakos Georgiou

|Jul 02, 2025
A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis.

Kan Li, Michael J Rudy, Yanmei Hu

Pageof 12

Frequent Collaborators

8 joint publications

Antonios Kolocouris

5 joint publications

Bin Tan

5 joint publications

Yu Chen

4 joint publications

Kan Li